| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/25/2013 | CN102178931B Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/25/2013 | CN102065900B Percutaneous absorption enhancer and transdermal preparation using the same |
| 09/25/2013 | CN102028664B Citicoline sodium tablets and preparation method thereof |
| 09/25/2013 | CN101991619B Pomegranate controlled-release pellets and preparation method thereof |
| 09/25/2013 | CN101917962B Microparticle film composition |
| 09/25/2013 | CN101905860B Hydroxyapatite hybridized nanometer crystal assembly, preparation method and application thereof |
| 09/25/2013 | CN101904834B Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
| 09/25/2013 | CN101897974B Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
| 09/25/2013 | CN101870719B Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof |
| 09/25/2013 | CN101601648B Sub-microemulsion used for intravenous injection of polyene yew alcohol phospholipid composite and preparation method thereof |
| 09/25/2013 | CN101578103B Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 09/25/2013 | CN101541194B Probiotic oral dosage forms |
| 09/25/2013 | CN101421293B Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/25/2013 | CN101374536B Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/25/2013 | CN101239190B Vitamin receptor binding drug delivery conjugates |
| 09/24/2013 | US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention |
| 09/24/2013 | US8541400 Monoacyl lipid, diacyl glycerol, tocopherol, and fragmentation agent; capable of self-dispersing to provide colloidal non-lamellar particles upon contact with an aqueous fluid; controlled-release formulations and for solubilising relatively insoluble compounds |
| 09/24/2013 | US8541392 Polymer controlled induced viscosity fiber system and uses thereof |
| 09/24/2013 | US8541375 Glycopeptide phosphonate derivatives |
| 09/24/2013 | US8541372 Isolated extracellular matrix material including subserous fascia |
| 09/24/2013 | US8541362 Cyclopropyl compounds and compositions for delivering active agents |
| 09/24/2013 | US8541023 Immunogenic compositions containing phospholipid |
| 09/24/2013 | US8541020 Washable, water resistant adhesive; crosslinked copolymer from such as acrylamide, diethyleneglycol methacrylate, n,n-methylenebisacrylamide, hexaglycerin and polyethyleneglycol; reusable bioelectrodes |
| 09/24/2013 | US8541018 Palatable suspending vehicle for pharmaceutical ingredients |
| 09/24/2013 | US8541013 Amphiphilic terpolymer having pH-sensitive hydrophobic units derived from a polyunsaturated fatty acid (9,12-Octadecadienoic Acid), hydrophilic units with polar groups (acrylic acid), and temperature-sensitive units (acryloylpiperidine), useful for drug delivery |
| 09/24/2013 | US8540964 Polyvalent conjugate vaccine for cancer |
| 09/24/2013 | CA2699894C Cholesterol derivatives of inhibitors of viral fusion |
| 09/24/2013 | CA2691587C Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a] pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4, tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepin |
| 09/24/2013 | CA2689856C Composition and method for stable injectable liquids |
| 09/24/2013 | CA2682064C Compositions for targeted imaging and therapy |
| 09/24/2013 | CA2680378C Method for determining physiological effects of hemoglobin |
| 09/24/2013 | CA2658491C Membrane-translocating peptides |
| 09/24/2013 | CA2604904C Self-sterilized, antiseptic collagen preparations, their use and method for producing them |
| 09/24/2013 | CA2595517C Drug carrier and drug carrier kit for inhibiting fibrosis |
| 09/24/2013 | CA2562550C Phosphorylcholine conjugates and corresponding antibodies |
| 09/24/2013 | CA2480656C Bioadhesive directed somatic cell therapy |
| 09/24/2013 | CA2471817C Labeling targeting agents with gallium-68 and gallium-67 |
| 09/24/2013 | CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/19/2013 | WO2013138783A1 A NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES |
| 09/19/2013 | WO2013138731A1 Polymeric conjugates of c1-inhibitors |
| 09/19/2013 | WO2013138730A1 Polymeric conjugates of c1-inhibitors |
| 09/19/2013 | WO2013138694A1 Polymeric conjugates of c-1 inhibitors |
| 09/19/2013 | WO2013138346A1 Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
| 09/19/2013 | WO2013138343A1 Controlled release formulations for the delivery of hif-1 inhibitors |
| 09/19/2013 | WO2013138240A1 Glycosaminoglycan and synthetic polymer materials for blood-contacting applications |
| 09/19/2013 | WO2013137755A1 Process for the preparation of polysaccharide nanoparticles |
| 09/19/2013 | WO2013137748A1 Long acting compositions |
| 09/19/2013 | WO2013137736A1 Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline |
| 09/19/2013 | WO2013137694A1 Solid matter for water-insoluble material coated with amorphous surfactant containing fatty acid having straight alkyl chain 직쇄 알킬체인을 가진 지방산을 포함하는 무수무복계면물질 |
| 09/19/2013 | WO2013137692A1 Method for manufacturing water-insoluble substance coated with amorphous surfactant and solid substance which becomes water-insoluble substance coated with amorphous surfactant when in water |
| 09/19/2013 | WO2013137627A1 Drug delivery conjugate capable of controlled release, and use thereof |
| 09/19/2013 | WO2013137441A1 Oral pharmaceutical composition |
| 09/19/2013 | WO2013136234A1 Transdermal delivery devices |
| 09/19/2013 | WO2013136075A1 Novel pharmaceutical formulations |
| 09/19/2013 | WO2013135930A1 Compounds derived from doxycycline such as haptens, conjugates and antibodies thereof, and immunochemical method for detecting doxycycline |
| 09/19/2013 | WO2013135892A1 Liposomal delivery system |
| 09/19/2013 | WO2013135471A1 Glycogen-based cationic polymers |
| 09/19/2013 | WO2013135359A1 Targeting aminoacid lipids |
| 09/19/2013 | WO2013135189A1 Solid dispersion improving absorption performance and preparation of same |
| 09/19/2013 | WO2013135187A1 Solid dispersion of improved adsorption performance and preparation thereof |
| 09/19/2013 | WO2013109675A3 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 09/19/2013 | WO2012155055A9 Integrin-targeted imaging of inflammation in vascular remodeling |
| 09/19/2013 | US20130245246 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative |
| 09/19/2013 | US20130245229 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 09/19/2013 | US20130245154 Controlled release dosage forms |
| 09/19/2013 | US20130245134 Degradable Therapeutic Delivery Device |
| 09/19/2013 | US20130245133 Amino acid derivatives and absorbable polymers therefrom |
| 09/19/2013 | US20130245131 Hydrogenation of Mixed Oxygenate Stream to Produce Alcohol |
| 09/19/2013 | US20130245123 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers |
| 09/19/2013 | US20130245118 Stable fatty acid-containing formulations |
| 09/19/2013 | US20130245109 Pharmaceutical formulation |
| 09/19/2013 | US20130245101 Liver Targeted Conjugates |
| 09/19/2013 | US20130245091 Compositions for Targeted Delivery of siRNA |
| 09/19/2013 | US20130245083 Methods of treatment with bioavailable compositions of metaxalone comprising nonvolatile liquids |
| 09/19/2013 | US20130245082 Bioavailable compositions of metaxolone comprising nonvolatile liquids and processes for producing the same |
| 09/19/2013 | US20130245055 Pharmaceutical Formulation Containing Gelling Agent |
| 09/19/2013 | US20130244982 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease |
| 09/19/2013 | US20130244975 Chemical conjugates for targeted degradation under reducing conditions |
| 09/19/2013 | US20130244972 Injectable chitosan mixtures forming hydrogels |
| 09/19/2013 | US20130244956 Camptothean-peptide conjugates and pharmaceutical compositions containing the same |
| 09/19/2013 | US20130244953 Dual secured therapeutic peptide delivery system |
| 09/19/2013 | US20130244952 Compositions and methods of delivery of pharmacological agents |
| 09/19/2013 | US20130244931 Novel GLP-1 Derivatives |
| 09/19/2013 | US20130243878 Biomaterials for delivery of blood extracts and methods of using same |
| 09/19/2013 | US20130243874 Nanoparticles coated with amphiphilic block copolymers |
| 09/19/2013 | US20130243868 Novel formulations |
| 09/19/2013 | US20130243833 Compressed formulations of ordered mesoporous silicas |
| 09/19/2013 | US20130243824 Sustained release composition containing sdf-1 |
| 09/19/2013 | US20130243805 Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus Infection |
| 09/19/2013 | US20130243767 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/19/2013 | US20130243751 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 09/19/2013 | US20130243719 Polymeric conjugates of active principles, their process of preparation and their polymeric intermediates |
| 09/19/2013 | US20130243707 Topical compositions |
| 09/19/2013 | US20130243700 Proteomic Antisense Molecular Shield and Targeting |
| 09/19/2013 | US20130243699 Biodegradable Magnetic Nanoparticles and Related Methods |
| 09/19/2013 | US20130243696 Compositions and Methods for the Treatment of Traumatic Brain Injury |
| 09/18/2013 | EP2639296A1 Stem cell suspension |
| 09/18/2013 | EP2638921A1 Gel sheet comprising lipidic peptide type gelling agent and polymeric compound |
| 09/18/2013 | EP2638906A1 Stabilized adhesive preparation containing donepezil |